
    
      The investigators seek to asses the effect of preexisting hypertension on the patient's
      response to treatment for severe hypertension in preeclampsia with severe features. The
      investigators hypothesize that successive administration of 40-60-80 mg of labetolol will
      reduce time to blood pressure control versus the standard dosing, 20-40-80 mg labetolol,
      recommended by the American College of Obstetricians and Gynecologists in 2015.
    
  